510(k) device
DAILIES AquaComfort Plus
Alcon Laboratories, Inc. · Lenses, Soft Contact, Daily Wear (LPL, Class II) · First FDA decision Jan 20, 2016, newest Nov 21, 2018Nearsightedness and refractive error
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
4
510(k) pathway
Device trials
27
Naming "DAILIES AquaComfort Plus"
MAUDE reports
135
Brand "DAILIES AquaComfort Plus", since 2015
PubMed studies
0
Mentioning "DAILIES AquaComfort Plus"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing DAILIES AquaComfort Plus
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 4 of 4 decisions filed under this name.
K181454 · Decided Nov 21, 2018 · 170 days after receipt
Device type: Lenses, Soft Contact, Daily Wear (LPL) · Ophthalmology
K172066 · Decided Aug 9, 2017 · 33 days after receipt
Device type: Lenses, Soft Contact, Daily Wear (LPL) · Ophthalmology
K161391 · Decided Nov 30, 2016 · 195 days after receipt
Device type: Lenses, Soft Contact, Daily Wear (LPL) · Ophthalmology
1 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Hydrophilic Contact LensesNational determinationOn the books80.4Updated Jun 11, 2020
Clinical trials
Device studies on ClinicalTrials.gov that name "DAILIES AquaComfort Plus", any status and sponsor, newest update first.
- Comparison of ACUVUE® OASYS MAX 1-Day Multifocal and DAILIES® AquaComfort Plus® MultifocalPivotal-lookingRecruiting
Johnson & Johnson Vision Care, Inc.Not on our public-company list
NCT07788521 · 150 participants (planned) · Start Sep 10, 2026 · Primary completion Dec 11, 2026
Device: Senofilcon A; Nelfilcon A · For: Visual Acuity
Sites: Longwood, Florida; Roswell, Georgia; St Louis, Missouri · 11 sites in all
- A Comparison of Two Daily Disposable Contact LensesPivotal-lookingTerminated
Johnson & Johnson Vision Care, Inc.Not on our public-company list
NCT00634101 · 129 participants · Start Jan 1, 2008 · Primary completion Mar 1, 2008
Device: nelfilcon A; narafilcon A · For: Refractive Error; Myopia
Sites: Bedford, United Kingdom; Brislington, United Kingdom; Broadstone, United Kingdom · 20 sites in all
Alcon ResearchNot on our public-company list
NCT04013789 · 79 participants · Start Aug 27, 2019 · Primary completion Nov 22, 2019
Device: DACP FreshTech contact lenses; DACP contact lenses · For: Refractive Ametropia; Myopia
Sites: Bloomington, Indiana
24 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "DAILIES AquaComfort Plus", and for the whole product code for context.
This brand
135 reports: 3 malfunction, 132 injury, 0 death
Whole product code LPL
2,348 reports: 156 malfunction, 2,159 injury, 0 death
Newest reports for this brand
- Dailies AquaComfort PlusInjury
1065835-2026-00014 · Received Oct 1, 2026 · Event dated Sep 15, 2026
Device type: Lenses, Soft Contact, Daily Wear (LPL)
Device problem as coded: Insufficient Device Problem Information; Material Split, Cut or Torn
Patient problem as coded: Conjunctivitis; Foreign Body Sensation in Eye; Red Eye(s); Blurred Vision; Excessive Tear Production; Eye Pain; Photophobia; Eye Irritation
- Dailies AquaComfort PlusInjury
CIBA VISION Asian Mfg and Logistics Pte Ltd.
3003657720-2026-00006 · Received Aug 22, 2026 · Event dated Jul 4, 2026
Device type: Lenses, Soft Contact, Daily Wear (LPL)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Bacterial Infection; Corneal Abrasion; Corneal Ulcer; Purulent Discharge; Blurred Vision; Excessive Tear Production; Eye Pain; Photophobia
1065835-2026-00005 · Received Apr 30, 2026 · Event dated Apr 7, 2026
Device type: Lens, Contact, (Disposable) (MVN)
Device problem as coded: Material Frayed; Material Split, Cut or Torn
Patient problem as coded: Corneal Ulcer; Foreign Body Sensation in Eye; Red Eye(s); Burning Sensation; Excessive Tear Production; Fluid Discharge; Eye Pain; Photophobia
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "DAILIES AquaComfort Plus"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code LPL.
- Bausch and Lomb Hefilcon A, B and C Hydrophilic Contact LensesBausch & Lomb, Inc. · PMA 2002
- Precision Ultraviolet (Vasurfilcon A) Hydrophilic Contact Lens for Extended WearAlcon Laboratories, Inc. · PMA 2001
- Hydrocurve 3 Toric (Bufilcon A) Extended Wear Soft (Hydrophilic) Contact LensCiba Vision Corporation · PMA 2001
- Softmate Ii, Hydrocurve Ii, and Hydrocurve II Aphakic (Bufilcon A)Ciba Vision Corporation · PMA 2000
- Pegavision (Polymacon) Daily Disposable Soft (Hydrophilic) Contact LensesPegavision Corporation · 510(k) 2026
- Dailies TOTAL1®Alcon Laboratories, Inc. · 510(k) 2026
- Precision1Alcon Laboratories, Inc. · 510(k) 2025
- Eye Secret 38 UV Aspheric (polymacon) and Air Light 38 UV Aspheric (polymacon) Soft (hydrophilic) Contact Lens for Daily WearYung Sheng Optical Co., Ltd. · 510(k) 2024
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.